0000792977-19-000128.txt : 20191010 0000792977-19-000128.hdr.sgml : 20191010 20191010170435 ACCESSION NUMBER: 0000792977-19-000128 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191008 FILED AS OF DATE: 20191010 DATE AS OF CHANGE: 20191010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FONTEYNE PAUL R. CENTRAL INDEX KEY: 0001727550 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10865 FILM NUMBER: 191146605 MAIL ADDRESS: STREET 1: C/O RESTORBIO, INC. STREET 2: 501 BOYLSTON STREET SUITE 6102 CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 6174983300 MAIL ADDRESS: STREET 1: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: AMAG PHARMACEUTICALS INC. DATE OF NAME CHANGE: 20070724 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 4 1 wf-form4_157074145269453.xml FORM 4 X0306 4 2019-10-08 0 0000792977 AMAG PHARMACEUTICALS, INC. AMAG 0001727550 FONTEYNE PAUL R. C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451 1 0 0 0 Common Stock 2019-10-08 4 A 0 4407 A 4407 D Stock Option (Right to Buy) 11.58 2019-10-08 4 A 0 6000 A 2029-10-08 Common Stock 6000.0 6000 D Stock Option (Right to Buy) 11.58 2019-10-08 4 A 0 9452 A 2029-10-08 Common Stock 9452.0 9452 D Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's 2019 Equity Incentive Plan (the "Plan") that will vest in seven equal monthly installments beginning on November 1, 2019; however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer. Not applicable. Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twenty-four equal monthly installments over two years from the date of grant. Grant of stock option pursuant to the Plan. This option will vest and become exercisable in seven equal monthly installments commencing November 1, 2019. Nancy R. Smith, attorney-in-fact 2019-10-10